LOXL2 and breast cancer: The novel findings in our study demonstrate that the proinflammatory cytokine OSM promotes the expression of LOXL2 in breast cancer cells, which significantly impacts collagen I fiber crosslinking, fiber alignment, and invasion (Fig. 7).